OVERVIEW
6th Regenerative Medicine Orthopaedic Summit (RMOS) is organized by Regenerative Medicine Orthopaedic Society (RMOS) and will be held from Apr 08 - 11, 2027 in Zagreb, Grad Zagreb, Croatia.
Description:
The lecture program will focus on the topics that are currently shaping the future of orthopaedics, sports medicine and regenerative medicine. Across four days, participants will join discussions on modern joint preservation, orthobiologics, interventional orthopaedics, ultrasound-guided procedures, energy-based therapies, sports medicine applications and the evolving role of regenerative medicine in musculoskeletal care.
One of the key themes of this year’s summit will also be “From Inflammation to Regeneration,” exploring the growing importance of inflammation, biologic therapies and multidisciplinary approaches in preserving joint health and improving long-term patient outcomes.
What’s Included:
- Full access to all RMOS congress lectures, plenary sessions and scientific presentations across 4 days.
- Access to regenerative medicine focused sessions covering orthobiologics, PRP, cellular therapies and clinical applications.
- Hands-on workshops, practical demonstrations and expert-led educational activities included in the program.
- International faculty, leading clinicians, researchers and regenerative medicine experts from around the world.
- Certificate of Attendance / CME information provided according to the final accreditation details.
- Coffee breaks, networking opportunities and dedicated meet-the-experts moments throughout the congress days.
- A science-driven RMOS program designed to connect physicians, researchers and innovators in regenerative medicine and orthobiologics.
KEY DATES
08 Apr, 2027
Event Start Date
11 Apr, 2027
Event End Date
TARGET AUDIENCE
PhysicianCliniciansScientistsStudentsResidentsSports Medicine PhysicianFellowsOrthopaedic SurgeonsMedical PractitionersRegenrative Medicine DoctorsOrthopedic FellowsSPECIALITIES
OrthopedicsOrthopaedic SurgerySUGGESTED HOTELS
CONFERENCE VENUE
TBD